TELESIS BIO INC (TBIO)

US1920032000 - Common Stock

3.23  -0.76 (-19.05%)

After market: 2.85 -0.38 (-11.76%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025
Revenue
YoY % growth
11.043M
67.93%
27.435M
148.44%
27.509M
0.27%
9.384M
-65.89%
9.792M
4.35%
EBITDA
YoY % growth
-34.466M
-122.43%
-44.814M
-30.02%
-32.83M
26.74%
-18.564M
43.45%
11.22M
160.44%
EBIT
YoY % growth
-35.374M
-116.21%
-46.485M
-31.41%
-35.15M
24.38%
-26.214M
25.42%
1.02M
103.89%
Operating Margin
-320.33%-169.44%-127.78%-279.35%10.42%
EPS
YoY % growth
N/A
-3,798.67%
-1.65
94.78%
-11.45
-593.94%
-25.45
-122.26%
-19.27
24.29%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24
EPS
Q2Q % growth
-2.91
29.78%
Revenue
Q2Q % growth
9.18M
31.58%
EBITDA
Q2Q % growth
-6.222M
-64.95%
EBIT
Q2Q % growth
-7.956M
-30.60%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-3.83
42.49%
-6.712.8842.93%
Q2 2024
Q2Q % growth
-7.62
-2,621.43%
-4.11-3.51-85.37%
Q1 2024
Q2Q % growth
-5.52
-1,391.89%
-4.22-1.30-30.72%
Q4 2023
Q2Q % growth
-4.14
-1,378.57%
-4.04-0.10-2.50%
Q3 2023
Q2Q % growth
-6.66
-1,485.71%
-5.45-1.21-22.27%
Q2 2023
Q2Q % growth
-0.28
44.00%
-0.330.0514.22%
Q1 2023
Q2Q % growth
-0.37
17.78%
-0.380.012.84%
Q4 2022
Q2Q % growth
-0.28
34.88%
-0.420.1433.59%
Q3 2022
Q2Q % growth
-0.42
-23.53%
-0.490.0714.22%
Q2 2022
Q2Q % growth
-0.50
52.83%
-0.530.034.82%
Q1 2022
Q2Q % growth
-0.45
-232.35%
-0.43-0.02-5.04%
Q4 2021
Q2Q % growth
-0.43
-95.45%
-0.38-0.05-12.92%
Q3 2021
Q2Q % growth
-0.34
-247.83%
-0.28-0.06-20.48%
Q2 2021
Q2Q % growth
-1.06
-82.76%
-0.36-0.70-192.74%
Q1 2021
Q2Q % growth
0.34
241.67%
-0.070.41594.71%
Q4 2020
Q2Q % growth
-0.22
54.17%
-0.240.029.85%
Q3 2020
Q2Q % growth
0.23
156.10%
0.210.0210.53%
Q2 2020
Q2Q % growth
-0.58
-1.75%
-0.44-0.14-32.99%
Q1 2020
Q2Q % growth
-0.24
67.57%
-0.470.2348.63%
Q4 2019
Q2Q % growth
-0.48
-269.23%
-0.43-0.05-12.80%
Q3 2019
Q2Q % growth
-0.41
57.73%
-0.470.0612.43%
Q2 2019
Q2Q % growth
-0.57
80.61%
-0.49-0.08-15.75%
Q1 2019
Q2Q % growth
-0.74 -0.49-0.25-51.94%
Q4 2018
Q2Q % growth
-0.13 -0.220.0940.72%
Q3 2018
Q2Q % growth
-0.97 -0.04-0.93-2,277.45%
Q2 2018
Q2Q % growth
-2.94 -0.63-2.31-364.90%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
1.57M
-71.78%
2.04M-470K-23.04%
Q2 2024
Q2Q % growth
1.55M
-82.09%
6.63M-5.08M-76.62%
Q1 2024
Q2Q % growth
3.44M
-45.54%
7.038M-3.598M-51.12%
Q4 2023
Q2Q % growth
6.977M
-26.32%
7.14M-163K-2.28%
Q3 2023
Q2Q % growth
5.564M
-16.64%
7.548M-1.984M-26.29%
Q2 2023
Q2Q % growth
8.652M
53.00%
8.772M-120K-1.37%
Q1 2023
Q2Q % growth
6.316M
12.07%
7.548M-1.232M-16.32%
Q4 2022
Q2Q % growth
9.469M
207.63%
7.344M2.125M28.94%
Q3 2022
Q2Q % growth
6.675M
139.59%
5.406M1.269M23.47%
Q2 2022
Q2Q % growth
5.655M
98.28%
4.539M1.116M24.59%
Q1 2022
Q2Q % growth
5.636M
142.20%
5.1M536K10.51%
Q4 2021
Q2Q % growth
3.078M
58.91%
3.91M-832K-21.28%
Q3 2021
Q2Q % growth
2.786M
70.40%
2.992M-206K-6.89%
Q2 2021
Q2Q % growth
2.852M
76.38%
2.601M251K9.65%
Q1 2021
Q2Q % growth
2.327M
67.77%
43.578M-41.251M-94.66%
Q4 2020
Q2Q % growth
1.937M
-37.98%
17.485M-15.548M-88.92%
Q3 2020
Q2Q % growth
1.635M
20.98%
53.669M-52.034M-96.95%
Q2 2020
Q2Q % growth
1.617M
-8.54%
2.864M-1.247M-43.54%
Q1 2020
Q2Q % growth
1.387M 1.709M-321.5K-18.82%
Q4 2019
Q2Q % growth

282.75%
3.123M%
Q3 2019
Q2Q % growth

-94.11%
1.352M%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -101.22% 0% -64.47%
Revenue0% -74.68% 0% -65.67%